Exact Sciences | EXAS - Operating Profit


Exact Sciences reported $-25M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Agilent USD 443M 66M Sep/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Exact Sciences USD -25M 22.85M Sep/2025
Hologic USD 237M 16M Dec/2025
Illumina USD 256M 6M Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -23.3M 10.8M Sep/2025
OraSure Technologies USD -6M 3.26M Sep/2024
Quidel USD -37.3M 667.5M Dec/2025
Repligen USD 19.97M 7.29M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veracyte USD 23.11M 8.8M Sep/2025
Waters USD 270.52M 78.4M Dec/2025